Prediction of tumour response by FDG-PET in patients with adenocarcinomas of the oesophagogastric junction

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 36, Issue 1, 2009, Pages 158-159

  Wieder, Hinrich ^a   Weber, Wolfgang ^b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

CANCER DIAGNOSIS; DRUG UPTAKE; ESOPHAGEAL ADENOCARCINOMA; HUMAN; LETTER; LOWER ESOPHAGUS SPHINCTER; POSITRON EMISSION TOMOGRAPHY;

ADENOCARCINOMA; ESOPHAGOGASTRIC JUNCTION; FLUORODEOXYGLUCOSE F18; HUMANS; POSITRON-EMISSION TOMOGRAPHY; TREATMENT OUTCOME;

EID: 57249097043     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-008-0973-0     Document Type: Letter

References (8)

1. E Bollschweiler AH Hölscher 2008 Prediction of tumour response by FDG-PET in patients with adenocarcinomas of the oesophagogastric junction Eur J Nucl Med Mol Imaging 35 1742 1743
2. H Wieder K Ott F Lordick K Becker A Stahl K Herrmann 2007 Prediction of tumor response by FDG-PET: comparison of the accuracy of single and sequential studies in patients with adenocarcinomas of the esophagogastric junction Eur J Nucl Med Mol Imaging 34 1925 1932
3. WA Weber K Ott K Becker HJ Dittler H Helmberger NE Avril 2001 Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging J Clin Oncol 19 3058 3065
4. K Ott WA Weber F Lordick K Becker R Busch K Herrmann 2006 Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction J Clin Oncol 24 4692 4698
5. F Lordick K Ott BJ Krause WA Weber K Becker HJ Stein 2007 PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial Lancet Oncol 8 797 805
6. Ilson DH, Bains M, Rizk N, Shah M, Rusch V, Capanu M, et al. Phase II trial of preoperative cisplatin-irinotecan followed by concurrent cisplatin-irinotecan and radiotherapy: PET scan after induction therapy may identify early treatment failure. Journal of Clinical Oncology, 2006 ASCO Annual Meeting Proceedings Part I. Vol 24, No. 18S (June 20 Supplement), 2006: 4023
7. C Gillham J Lucey M Keogan G Duffy V Malik A Raouf 2006 (18)FDG uptake during induction chemoradiation for oesophageal cancer fails to predict histomorphological tumour response Br J Cancer 95 1174 1179
8. B Smithers G Couper J Thomas D Wong D Gotley I Martin 2008 Positron emission tomography and pathological evidence of response to neoadjuvant therapy in adenocarcinoma of the esophagus Dis Esophagus 21 151 158